APA (7th ed.) Citation

CE, T., JE, B., CD, D., HH, F., JS, M., A, S., . . . LM, S. (2026). Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growth. Molecular therapy : the journal of the American Society of Gene Therapy, 34(5), 2963. https://doi.org/10.1016/j.ymthe.2026.01.033

Chicago Style (17th ed.) Citation

CE, Tocheny, et al. "Therapeutic Delivery of Albumin-binding SiRNA Targeting IRS2 to Diverse Cell Types Reduces Mammary Tumor Growth." Molecular Therapy : The Journal of the American Society of Gene Therapy 34, no. 5 (2026): 2963. https://doi.org/10.1016/j.ymthe.2026.01.033.

MLA (9th ed.) Citation

CE, Tocheny, et al. "Therapeutic Delivery of Albumin-binding SiRNA Targeting IRS2 to Diverse Cell Types Reduces Mammary Tumor Growth." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 34, no. 5, 2026, p. 2963, https://doi.org/10.1016/j.ymthe.2026.01.033.